|
Federal
Register Notices > Notice
of Registration - 2005 > Cerilliant
Corporation,
FR Doc 05-4205 [Federal Register: March 4, 2005
(Volume 70, Number 42)] [Notices] [Page 10676-10677] From the Federal
Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04mr05-103]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice
of Registration
By Notice dated September 28, 2004, and published
in the Federal Register on October 14, 2004, (69 FR 61043), Cerilliant
Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78664, made
application by renewal to the Drug Enforcement Administration (DEA) for
registration as a bulk manufacturer of the basic classes of controlled
substances listed in Schedules I and II:
| Drug |
Schedule |
| Cathinone (1235) |
I |
| Methcathinone (1237) |
I |
| N-Ethylamphetamine (1475) |
I |
| N,N-Dimethylamphetamine (1480) |
I |
| Aminorex (1585) |
I |
| 4-7Methylaminorex (cis isomer)
(1590) |
I |
| Gamma hydroxybutyric acid
(2010) |
I |
| Methaqualone (2565) |
I |
| Alpha-Ethyltryptamine (7249) |
I |
| Lysergic acid diethylamide
(7315) |
I |
| Tetrahydrocannabinols
(7370) |
I |
| Mescaline (7381) |
I |
| 3,4,5-Trimethoxyamphetamine
(7390) |
I |
| 4-Bromo-2,5-dimethoxyamphetamine
(7391) |
I |
| 4-Bromo-2,5-dimethoxyphenethylamine
(7392) |
I |
| 4-Methyl-2,5-dimethoxyamphetamine
(7395) |
I |
| 2,5-Dimethoxyamphetamine (7396) |
I |
| 2,5-Dimethoxy-4-ethylamphetamine
(7399) |
I |
| 3,4-Methylenedioxyamphetamine
(7400) |
I |
| 5-Methoxy-3,4-methylenedioxyamphetamine
I (7401) |
I |
| N-Hydroxy-3,4-methylendioxyamphetamine
I (7402) |
I |
| 3,4-Methylendioxy-N-ethylamphetamine
(7404) |
I |
| 3,4-Methylenedioxymethamphetamine
(7405) |
I |
| 4-Methoxyamphetamine (7411) |
I |
| Bufotenine (7433) |
I |
| Diethyltryptamine (7434) |
I |
| Dimethyltryptamine (7435) |
I |
| Psilocybin (7437) |
I |
| Psilocyn (7438) |
I |
| Acetyldihydrocodeine (9051) |
I |
| Benzylmorphine (9052) |
I |
| Codeine-N-oxide (9053) |
I |
| Dihydromorphine (9145) |
I |
| Heroin (9200) |
I |
| Hydromorphinol (9301) |
I |
| Methyldihydromorphine (9304) |
I |
| Morphine-N-oxide (9307) |
I |
| Normorphine (9313) |
I |
| Pholcodine (9314). I |
I |
| Acetylmethadol (9601) I |
I |
| Allylprodine (9602). I |
I |
| Alphacetylmethadol except
levo-alphacetylmethadol (9603) |
I |
| Alphameprodine (9604) |
I |
| Alphamethadol (9605) |
I |
| Betacetylmethadol (9607) |
I |
| Betameprodine (9608) |
I |
| Betamethadol (9609) |
I |
| Betaprodine (9611) |
I |
| Hydroxypethidine (9627) |
I |
| Noracymethadol (9633) |
I |
| Norlevorphanol (9634) |
I |
| Normethadone (9635) |
I |
| Trimeperidine (9646) |
I |
| Phenomorphan (9647) |
I |
| Para-Fluorofentanyl
(9812) |
I |
| 3-Methylfentanyl (9813) I |
I |
| Alpha-Methylfentanyl (9814) |
I |
| Acetyl-alpha-methylfentanyl
(9815) |
I |
| Beta-hydroxyfentanyl (9830) |
I |
| Beta-hydroxy-3-methylfentanyl
(9831) |
I |
| Alpha-Methylthiofentanyl
(9832) |
I |
| 3-Methylthiofentanyl (9833) |
I |
| Thiofentanyl (9835) |
I |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Phenmetrazine (1631) |
II |
| Methylphenidate (1724) |
II |
| Ambobarbital (2125) |
II |
| Pentobarbital (2270) |
II |
| Secobarbital (2315) |
II |
| Glutethimide (2550) |
II |
| Nabilone (7379) |
II |
| 1-Phenylcyclohexylamine II
(7460) |
II |
| Phencyclidine (7471) |
II |
| 1-Piperidinocyclohexanecarbonitrile
(8603) |
II |
| Alphaprodine (9010) |
II |
| Cocaine (9041) |
II |
| Codeine (9050) |
II |
| Dihydrocodeine (9120) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Diphenoxylate (9170) |
II |
| Benzoylecgonine (9180) |
II |
| Ethylmorphine (9190) |
II |
| Hydrocodone (9193) |
II |
| Levomethorphan (9210) |
II |
| Levorphanol (9220) |
II |
| Isomethadone (9226) |
II |
| Meperidine (9230) |
II |
| Methadone (9250) |
II |
| Methadone-intermediate (9254) |
II |
| Dextropropoxyphene, bulk
(non-dosage forms) (9273) |
II |
| Morphine (9300) |
II |
| Thebaine (9333) |
II |
| Levo-alphacetylmethadol (9648) |
II |
| Oxymorphone (9652) |
II |
| Noroxymorphone (9668) |
II |
| Racemethorphan (9732) |
II |
| Alfentanil (9737) |
II |
| Sufentanil (9740) |
II |
| Fentanyl (9801) |
II |
The company plans to manufacture small quantities
of the listed controlled substances to make reference standards for
distribution to its customers.
No comments or objections have been received. DEA
has considered the factors in 21 U.S.C. 823(a) and determined that the
registration of Cerilliant Corporation to manufacture the listed basic
classes of controlled substances is consistent with the public interest
at this time. DEA has investigated Cerilliant Corporation to ensure that
the company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance with
state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21
U.S.C. 823, and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: Febuary 22, 2005.
William J. Walker,
Deputy Assistant Administrator,
Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 05-4205 Filed 3-3-05; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
Back to
Top
Registration
Support
Toll Free Number: 1-800-882-9539
ARCOS
| Career Opportunities | Chemical Program |
Controlled
Substance Schedules | Drugs and
Chemicals of Concern
Electronic Commerce Initiatives | | Federal Register
Notices | Import Export | Links
| Meetings
and Events | NFLIS
Offices &
Directories | On-Line Forms & Applications |
Program
Description | Publications
|
Questions & Answers | Quotas
Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
Contact Us | Home
| Hot
Items | Site Map | Search | What's New
|
